3Christophe Rosty, Laurence Christa, Scott Kuzdzal, et al. Identification of hepatocarcinoma - intestine - pancreas/pancreatltls - associated protein Ⅰ as a biomarker for uancreatic ductal adenocarcinoma by protein blochip technology [J ]. Cancer Research, 2002, 62:1868 - 1875.
7Vlahou A, Schellbammer PF, Mendrinos S, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine[J]. An J Pathol, 2001, 158(4) : 1491 - 1502.
8Wright GL, Cazares LH, Leunq SM, et al. Protein chip(R) surface enhanced laser desorption/ionization(SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures[J ]. Prostate Cancer Prostatic Dis, 1999, 2(5/6) :264 - 276.
9Paweletz GP, Trock B, Pennanen M, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI - TOF: potential for new biomarkers to aid in the diagnosis of breast cancer[J]. Dis Markers, 2001, 17(4) : 301 - 307.
8[2]Pedoe - Tunstall H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the world Health Organization MONICA Project [J]. Circulation, 1994,90: 583.
9[3]Goldberg R, Gore J, Alpert J, et al. Incidence and case fatality rates of acute myocardial infarction ( 1975 - 1984): The Worcester Heart Attack Study[J]. Am Heart J, 1988,115: 761.
10[4]Ellis AK. Scrum protein meassurements and the diagnosis of acute myocardial infarction[J]. Circulation, 1991,83:1101.
3Merchant M,Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectromelay[ J]. Electrophoresis,2000,21 (6) : 1164 - 1177.
4Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments [ J]. Bioinformatics ,2004,20 (5) :777 - 785.
5Mclerran D, Grizzle WE, Feng ZD, et al. SELDI-TOF-MS whole serum proteomic profiling with IMAC surface dose not reliably detect prostate cancer[J]. Clin Chem,2008,54( 1 ) :53 -60.
6Diamandis EP. Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics [ J ]. Clin Chem, 2003,49(8) :1272 - 1275.
7Check E. Proteomics and cancer:running before we can walk[ J]. Nature,2004,429 ( 6991 ) : 496 - 497.
8Poon TC. Opportunities and limitations of SELDI-TOF-MS in biomedical research:practical advices[ J]. Expert Rev Proteomics, 2007,4( 1 ) :51 -62.
9Marshall J, Kupchak P, Zhu W, et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction [J]. I Proteome Res,2003,2(4) :361 -372.
10Timms JF,Arslan-Low E,Gentry-Maharaj A,et al. Preanalytic influence of sample handling on SELDI-TOF serum protein profiles [ J]. Clin Chem,2007,53 (4) :645 - 656.
